Today's Date
High Dose Immunosuppression and Autologous Stem Cell Transplantation for Multiple Sclerosis
(
HALT-MS
)
ITN Protocol #:
ITN033AI
Branded Name:
HALT-MS
ClinicalTrials.Gov ID:
NCT00288626Treatment Protocol #:
BEAM + rATG
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
A Phase II Study of High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, Melphalan, Thymoglobulin and Autologous CD34+ Hematopoietic Stem Cell Transplant for the Treatment of Poor Prognosis Multiple Sclerosis
Clinical Operations Manager
ITN Biologist
ITN Biostat
NIAID Project Manager
Rho Scientist
Study Personnel:
